Table 2.
Control subjects | Case patients | Crude model1 | Adjusted model2 | ||||
---|---|---|---|---|---|---|---|
| |||||||
N, % | N, % | OR | 95% CI | OR | 95% CI | ||
H. pylori serology | |||||||
Negative | 241 (53.9) | 250 (56.0) | 1.00 | 1.00 | |||
Positive | 206 (46.1) | 196 (44.0) | 0.91 | 0.68, 1.21 | 0.96 | 0.70, 1.31 | |
CagA serology | |||||||
Negative | 306 (68.9) | 302 (68.3) | 1.00 | 1.00 | |||
Positive | 138 (31.1) | 140 (31.7) | 1.02 | 0.76, 1.38 | 1.07 | 0.77, 1.48 | |
H. pylori and CagA serology | |||||||
H. pylori−, CagA− | 214 (48.3) | 218 (49.5) | 1.00 | 1.00 | |||
H. pylori+ or CagA+ | 231 (51.9) | 224 (50.7) | 0.94 | 0.70, 1.25 | 0.99 | 0.73, 1.35 | |
H. pylori−, CagA+ | 25 (5.6) | 28 (6.4) | 1.11 | 0.61, 2.02 | 1.14 | 0.59, 2.22 | |
H. pylori+, CagA− | 91 (20.5) | 82 (18.6) | 0.88 | 0.61, 1.27 | 0.94 | 0.63, 1.38 | |
H. pylori+, CagA+ | 113 (25.5) | 112 (25.4) | 0.96 | 0.68, 1.37 | 1.04 | 0.63, 1.38 | |
Sub-analysis stratified by ABO blood group (N=278, case-control pairs) | |||||||
O blood group | |||||||
H. pylori−, CagA− | 59 (21.2) | 49 (17.6) | 1.00 | 1.00 | |||
H. pylori+ or CagA+ | 52 (18.7) | 45 (16.2) | 1.06 | 0.57, 1.96 | 1.17 | 0.60, 2.30 | |
Non-O blood type | |||||||
H. pylori−, CagA−, | 76 (27.3) | 86 (30.9) | 1.00 | 1.00 | |||
H. pylori+ or CagA+ | 91 (32.7) | 98 (35.3) | 0.94 | 0.60, 1.46 | 0.86 | 0.54, 1.38 |
Crude conditional logistic regression model was inherently adjusted for the matching factors, including study center, sex, age at blood collection (±3 years), date of blood donation (±3 months), time of blood donation (±2 h), and fasting status (<3h, 3–6h or >6 after the last meal).
Adjusted conditional logistic regression model was inherently controlled for the matching factors, and was further adjusted for height, waist-to-hip ratio, smoking status (never, former or current) and diabetes mellitus status (no or yes).